Results of hepatic arterial infusion chemotherapy in patients with unresectable liver metastases

Viszeralmedizin: Gastrointestinal Medicine and Surgery

Volumn 27, Issue 5, 2011, Pages 397-401

  Goi, Takanori ^a   Sawai, Katsuji ^a   Koneri, Kenji ^a   Katayama, Kanji ^a   Yamaguchi, Akio ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Colorectal cancer; HAIC; Hepatic arterial infusion chemotherapy; Unresectable liver metastases

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; ADVANCED CANCER; ANOREXIA; ARTICLE; CANCER PATIENT; COLORECTAL CANCER; DIARRHEA; DRUG EFFICACY; DRUG INFUSION; FEMALE; HUMAN; INOPERABLE CANCER; LIVER CANCER; LIVER FAILURE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PIGMENTATION; SIDE EFFECT; SURVIVAL RATE; TREATMENT RESPONSE;

EID: 81355139638     PISSN: 16626664     EISSN: 16626672     Source Type: Journal    
DOI: 10.1159/000332937     Document Type: Article

References (12)

1. Obrand DI, Gordon PH: Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 1997;40:15-24. (Pubitemid 27056393)
2. Kotake K, Honjo S, Koyama Y: Multi-institutional registry of large bowel cancer in Japan, cases treated in 1996. Japan, Japanese Society for Cancer of the Colon and Rectum Press, 2000.
3. Kotake K, Honjo S, Koyama Y: Multi-institutional registry of large bowel cancer in Japan, cases treated in 1997. Japan: Japanese Society for Cancer of the Colon and Rectum Press, 2001.
4. Kotake K, Honjo S, Koyama Y: Multi-institutional registry of large bowel cancer in Japan, cases treated in 1998. Japan: Japanese Society for Cancer of the Colon and Rectum Press, 2003.
5. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Levi F, Bismuth H: Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052-1061.
6. Curley SA, Izzo F, Abdalla E, Vauthey JN: Surgical treatment of colorectal cancer metastasis. Cancer and Metast Rev 2004;23:165-182. (Pubitemid 38221602)
7. Ruers T, Bleichrodt RP: Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002;38:1023-1033. (Pubitemid 34442330)
8. Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K, Oya M, Maeda K, Hirai T, Kameyama M, Shirouzu K, Muto T: Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery 2007;141:67-75. (Pubitemid 44918081)
9. Murata S, Moriya Y, Akasu T, Fujita S, Sugihara K: Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 1998;83:1086-1093. (Pubitemid 28419060)
10. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghémard O, Levi F, Bismuth H: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004;240:644-657.
11. Collins JM: Pharmacokinetic rationale for intraarterial therapy; in Howell SB (ed): Intra-Arterial and Intracavitary Cancer Chemotherapy. Boston, MA, Martinus Nijhoff Publishers, 1984.
12. Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE 2nd, Zhang C, Mayer RJ: Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 2006; 24:1395-1403. (Pubitemid 46622004)